Sentence examples for death and differences from inspiring English sources

We designed a retrospective cohort study to determine the vital prognosis, causes of death, and differences in outcome after intact and ruptured AAA.

These data were analyzed using Kaplan-Meier censoringensonICU on ICU discharge or death, and differences between groups were assessed using the log-rank test and Cox proportional hazards models, adjusted for the same baseline characteristics with P < 0.25.

Regardless of the exact origin of artificial alterations in sulfur redox following animal death, if a suitable protocol is not employed, the GSSG/GSH ratio increases rapidly following animal death, and differences present in vivo may be lost; this has been the source of many confounding results in previous studies.

The tumultuous relationship, supported by some of TV's most-memorable characters, garnered fans from across the country and laid the foundation for riveting episodes that redefined and meditated on death and the differences between being and being.

One of the main mechanisms of RT/CT is the induction of cell death, and therefore differences in treatment sensitivity may depend on the susceptibility of LC cells to undergo cell death.

The staurosporine-provoked expression profile for all these genes corroborate their role in cell death and expression differences observed in Δ czt-1 suggest that they are under the control of the transcription factor.

As silly as this intricate level of maximum optimization might sound, particularly in relation to a herd of cows that spend much of the day staring blankly or relieving themselves,Watson said, it could mean the difference between a cow's healthy milking or premature death — and the difference between making or losing hundreds of thousands of dollars every year.

The cyclic stretching regimens were well tolerated by the tenocytes (i.e. no evidence of cell death and no difference in RNA concentrations between stimulated and unstimulated groups).

However, there was no procedure-related death and no difference in complication-associated outcomes between patients who underwent invasive diagnostic procedures with and without lung biopsy (see Additional file 1, Table S4).

This is unlikely to be due to toxicity as maraviroc was non-toxic with respect to cell proliferation in culture, and we found no evidence for increased cell death and no difference in cell density between segments cultured with vehicle or CCR5 antagonists.

This difference accounted for around 2% of deaths and produced differences in standardised mortality ratios of 0.6% or less for each four year period.